OCGN:NASDAQ
Ocugen Inc
$1.04
0.00%
(0.00) 1D
$1.05
arrow_upward
+0.96% (+0.0100)todayPre-market
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCGN...
Open
$1.05
High
$1.12
Low
$1.04
Mkt. cap
345.89M
Avg. vol.
7.35M
Volume
45.24K
52-wk high
$2.72
52-wk low
$0.97
EPS
-$0.25
Beta
2.27
Shares outstanding
339.11M
No. of employees
116
Open
$1.05
High
$1.12
Low
$1.04
Mkt. cap
345.89M
Avg. vol.
7.35M
Volume
45.24K
52-wk high
$2.72
52-wk low
$0.97
EPS
-$0.25
Beta
2.27
Shares outstanding
339.11M
No. of employees
116
News stories
From web sources and news partners
AD HOC NEWS
·
8 hours ago
Ocugen stock gained 3.37 percent on October 6 as Europe expands
Yahoo Finance
·
10 hours ago
OCGN 8-K & SEC Filings
AD HOC NEWS
·
19 hours ago
Ocugen's Amsterdam Office Opens While a 250 Million Share Question Stalls at the Ballot Box
Stock Titan
·
23 hours ago
Key data from Ocugen's three gene therapy programs for blindness are expected in 2027 and 2028.
About Ocugen Inc
CEOShankar Musunuri
Employees116
Founded2013
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteocugen.com